Information Provided By:
Fly News Breaks for September 3, 2015
WMGI, TRNX, IART
Sep 3, 2015 | 09:56 EDT
Piper Jaffray analyst Matt O'Brien said he views Integra LifeSciences' (IART) acquisition of Tornier's (TRNX) U.S. ankle replacement and silastic toe replacement products as a "win win" for both companies. O'Brien estimates a deal price between $25M-$35M, saying he believes Integra gets a "quality total ankle system at an attractive price," while adding that Tornier clears the last hurdle with the FTC for its Wright Medical (WMGI) deal with the divestiture. O'Brien maintains his Overweight rating and $72 price target on Integra shares.
News For IART;TRNX;WMGI From the Last 2 Days
There are no results for your query IART;TRNX;WMGI